百利天恒股价跌5.02%，中金基金旗下1只基金重仓，持有1.56万股浮亏损失28.23万元

Group 1 - The core point of the news is that Baili Tianheng's stock price has dropped by 5.02%, currently trading at 343.18 CNY per share, with a total market capitalization of 141.69 billion CNY [1] - Baili Tianheng Pharmaceutical Co., Ltd. is located in Chengdu, Sichuan Province, and was established on August 17, 2006, with its listing date on January 6, 2023. The company's main business involves the research, production, and sales of pharmaceuticals [1] - The revenue composition of Baili Tianheng shows that 99.57% is recognized at a specific point in time, while 0.43% is recognized over a period [1] Group 2 - From the perspective of major fund holdings, one fund under CICC holds Baili Tianheng as a top ten position. CICC New Medicine A (006981) held 15,600 shares in the second quarter, accounting for 4.11% of the fund's net value, with an estimated floating loss of approximately 282,300 CNY today [2] - CICC New Medicine A (006981) was established on May 14, 2019, with a latest scale of 928.39 million CNY. The fund has achieved a return of 31.11% this year, ranking 1653 out of 4220 in its category, and a return of 27.79% over the past year, ranking 2025 out of 3857 [2] - The fund manager of CICC New Medicine A is Ding Tianyu, who has been in the position for 4 years and 290 days, with the fund's total asset scale at 132 million CNY. The best return during his tenure is 17.28%, while the worst return is -15.75% [3]